piracetam has been researched along with adenosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Matar, KM | 1 |
| Carvalho, FB; Girardi, BA; Gutierres, JM; Jaques, JA; Leal, DB; Marisco, PC; Mello, CF; Pimentel, VC; Rosa, MM; Rubin, MA; Salla, AP; Schetinger, MR | 1 |
3 other study(ies) available for piracetam and adenosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic drug monitoring.
Topics: Adenosine; Anticonvulsants; Calibration; Chromatography, Liquid; Drug Monitoring; Drug Stability; Drug Storage; Epilepsy; Freezing; Humans; Levetiracetam; Metabolic Clearance Rate; Piracetam; Quality Control; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Time Factors | 2008 |
Piracetam prevents scopolamine-induced memory impairment and decrease of NTPDase, 5'-nucleotidase and adenosine deaminase activities.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Deaminase; Adenosine Triphosphate; Animals; Behavior, Animal; Male; Memory Disorders; Neuroprotective Agents; Piracetam; Pyrophosphatases; Rats; Rats, Wistar; Scopolamine; Synaptosomes; Thiobarbituric Acid Reactive Substances | 2013 |